Neutropenic fever in COVID-19 in kidney transplant patient

Rev Med Virol. 2021 Jan;31(1):1-2. doi: 10.1002/rmv.2156. Epub 2020 Aug 28.

Authors

Akram Al-Makki¹, Tim Taber²

Affiliations

¹ Graduate Medical Education, Nephrology Department and Inpatient Dialysis Unit, Indiana University Health-Arnett, Lafayette, Indiana, USA.
² Clinical Medicine, Indiana University School of Medicine, University Hospital, Indianapolis, Indiana, USA.

PMID: 32856324
DOI: 10.1002/rmv.2156

No abstract available

Keywords: COVID-19; kidney transplant; neutropenic fever.

Publication types

Case Reports
Letter

MeSH terms

Adult
Azithromycin / therapeutic use
COVID-19 / pathology*
COVID-19 Drug Treatment
Cefepime / therapeutic use
Febrile Neutropenia / pathology*
Febrile Neutropenia / virology
Female
Humans
Hydroxychloroquine / therapeutic use
Immunocompromised Host*
Kidney Transplantation
SARS-CoV-2 / genetics
Transplant Recipients*

Substances

Hydroxychloroquine
Cefepime
Azithromycin